ADHD Trial, Recruiting NCT06133231 Sponsor: Oregon Health and Science University Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT06133231
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between the ages of 6 and 17 years old at the time of enrollment who have suspected or confirmed ADHD based on parent report
  • Children whose symptoms meet a certain threshold on a standard ADHD checklist (called the CASI-5), occurring in more than one setting, and who also show at least one symptom of irritability from a related checklist
  • Children who are able and willing to swallow up to 8 pills per day
  • Children who have not taken any medication for at least 2 weeks before the study begins
  • Families who are willing to collect blood and urine samples at home using provided kits
  • Children who are able to communicate in English
  • Children whose parent or caregiver identifies them as Black/African American, Hispanic/Latina/o, or of more than one race (the trial aims for this to represent 70–100% of participants)

Who may not be able to join:

  • Children who have a neurological disorder
  • Children who have certain medical conditions, such as cancer, kidney or liver disease, diabetes, or an overactive thyroid
  • Children who have a psychiatric condition that requires hospitalisation
  • Children who have a known allergy to any ingredient in the supplement being studied
  • Children with a uterus who are sexually active, pregnant, or possibly pregnant
  • Children who have a condition affecting how their body processes minerals (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jeanette Johnstone, PhD, Oregon Health and Science University

Phone: 503-893-5873

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 January 2024
Est. completion
1 September 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility measured by count of consumed multinutrients; Abbreviated Acceptability Rating Profile - 7 questions on a 6-point Likert scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov